PTG Poltreg S.A.

4.549USD18.30 PLN · GPW0.00%Mkt Cap: 26.92M USDP/E: —

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases in Poland. Its product pipeline includes PTG-OO7 + Rituximab which is in phase II clinical trial to treat presymptomatic T1…

Key Statistics

Company
Market Cap26.92M USD
Enterprise Value23.15M USD
Revenue (TTM)59.67K USD
Gross Profit-1.33M USD
Net Income (TTM)-6.46M USD
Revenue/Share0.01 USD
Last Price4.549 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees34
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLPLTRG00038
Valuation
P/E (Trailing)—
P/E (Forward)-1.20
PEG—
EV/EBITDA-4.85
EV/Revenue387.95
P/S451.13
P/B2.22
EPS (TTM)-1.24 USD
EPS (Forward)—
52W Range
3.97814% of range8.129
52W High8.129 USD
52W Low3.978 USD
Profitability
Gross Margin0.00%
Oper. Margin-10056.67%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-60.00%
ROA-35.64%
ROIC-79.00%
ROCE-41.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.93M USD
CapEx (TTM)134.99K USD
FCF Margin-5975.78%
FCF Yield-13.25%
Net Debt-3.77M USD
Net Debt/EBITDA0.79
Net Debt/FCF—
Balance Sheet
Debt/Equity0.18
Current Ratio3.49
Quick Ratio3.30
Book Value/Sh2.05 USD
Cash/Share0.95 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)7.284 USD
Upside (mean)+60.1%
Target Range7.284 USD – 7.284 USD
# Analysts1
Ownership
Shares Out.5.92M
Float3.83M
Insiders32.43%
Institutions29.26%
Technical
SMA 505.066 (-10.2%)
SMA 2005.250 (-13.3%)
Beta0.77
S&P 52W Chg12.00%
Avg Vol (30d)4.30K
Avg Vol (10d)3.95K
Technical Indicators
RSI (14)38.9
MACD-0.5765
MACD Signal-0.2724
MACD Hist.-0.3041
BB Upper5.442 USD
BB Middle4.975 USD
BB Lower4.507 USD
BB Width18.80%
ATR (14)0.2902 USD
Vol Ratio (20d)0.21x

About Poltreg (WSE: PTG)

›

Poltreg (WSE: PTG) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 34 employees.

The shares were at 18.30 PLN on 19 November 2026, down 39.0% over 52 weeks. Its 52-week range is 16.00 PLN to 32.70 PLN: the price is 44.0% below the high and 14.4% above the low.

Its market capitalisation is 108.27M PLN.

Poltreg reports return on equity of -60.0%.

It holds more cash than debt, a net cash position of 15.16M PLN. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 29.30 PLN is 60.1% above the current price.